This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWP
The Zacks Analyst Blog Highlights Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys
by Zacks Equity Research
Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys are included in this Analyst Blog.
Top Stock Reports for Berkshire Hathaway, Roche & Thermo Fisher Scientific
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Roche Holding AG (RHHBY) and Thermo Fisher Scientific Inc. (TMO).
Should iShares Russell Mid-Cap ETF (IWR) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWR
Here's How Much You'd Have If You Invested $1000 in Synopsys a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Synopsys (SNPS) Up 4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights Analog Devices, Estee Lauder, Aon, Synopsys and Parker-Hannifin
by Zacks Equity Research
Analog Devices, Estee Lauder, Aon, Synopsys and Parker-Hannifin are included in this Analyst Blog.
Top Research Reports for Analog Devices, The Estee Lauder & Aon
by Santanu Roy
Today's Research Daily features new research reports on 16 major stocks, including Analog Devices, Inc. (ADI), The Estee Lauder Companies Inc. (EL) and Aon plc (AON).
Synopsys (SNPS) Beats Q1 Earnings and Sales Estimates
by Zacks Equity Research
Synopsys' (SNPS) first-quarter results reflect benefits from a solid demand for its products amid rapid adoption of Big Data, faster computation and Machine Learning.
Synopsys (SNPS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Synopsys (SNPS) delivered earnings and revenue surprises of 4.80% and 0.61%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Intel, Synopsys, FedEx, First Solar and Synchrony Financial
by Zacks Equity Research
Intel, Synopsys, FedEx, First Solar and Synchrony Financial are part of the Zacks top Analyst Blog.
Synopsys (SNPS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Synopsys' (SNPS) Q1 performance is likely to have benefited from the increasing global design activity and customer engagements in solutions like high-performance cloud computing and more.
Top Analyst Reports for Intel, Synopsys & FedEx
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Intel Corporation (INTC), Synopsys, Inc. (SNPS) and FedEx Corporation (FDX).
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWP
Should iShares Russell MidCap ETF (IWR) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWR
Top Research Reports for PepsiCo, Verizon Communications & Sanofi
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including PepsiCo, Inc. (PEP), Verizon Communications Inc. (VZ) and The Sanofi (SNY).
Should Vanguard MidCap ETF (VO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VO
3 Top Tech Stocks With Impressive Growth Trajectories
by Derek Lewis
2022 was anything but fun for tech stocks, with a hawkish Federal Reserve weighing heavily on sentiment within the sector all year. Still, despite the headwinds, the outlook for all three of these companies has recently turned bright.
Strength Seen in OptimizeRx Corp. (OPRX): Can Its 10.1% Jump Turn into More Strength?
by Zacks Equity Research
OptimizeRx Corp. (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Why Is Synopsys (SNPS) Down 10% Since Last Earnings Report?
by Zacks Equity Research
Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
8 Reasons Why You Should Invest in Synopsys (SNPS) Stock Now
by Zacks Equity Research
Synopsys (SNPS) is a stock that investors can consider adding to their portfolio amid the current stock market volatilities.
Synopsys (SNPS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Synopsys (SNPS) closed at $320.21 in the latest trading session, marking a -0.47% move from the prior day.
Here is Why Growth Investors Should Buy Synopsys (SNPS) Now
by Zacks Equity Research
Synopsys (SNPS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks.com featured highlights include The Chefs' Warehouse, Synopsys, Enphase Energy, ONEOK and Fabrinet
by Zacks Equity Research
The Chefs' Warehouse, Synopsys, Enphase Energy, ONEOK and Fabrinet are part of the Zacks Screen of the Week article.